Effect of 12 Weeks of Resistive Exercises Versus Aerobic Exercises in Overweight Hypertensive Postmenopausal Women

Exercise and Menopausal Hypertension

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03637985

Acronym

exercise

Enrollment

Registered

2018-08-20

Start date

2017-09-01

Completion date

2018-08-01

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise

Keywords

resistive exercises, aerobic, Menopause, hypertension

Brief summary

Sixty postmenopausal women participated in this study from gynecological outpatient clinic, at Al-Zahra universal Hospital, Al Azhar University, and Cairo. They were first diagnosed to be hypertensive in their early postmenopausal period .Their blood pressure ranged between 140/90mmHg to 170/105mmHg, their ages ranged from 50 to 60 years and their body mass index ranged from 30:35 kg/m2.

Detailed description

The participants were divided randomly according to closed envelop into three equal groups in number: Group A (RE) consisted of twenty women who participated in the resistive exercise program. Group B (AE) group: consisted of twenty women who participated in an aerobic exercise program. All patients in both groups (A & B) participated in the exercises three times per week for twelve weeks and every session lasted for 45 min and continues their antihypertensive medication

Interventions

DEVICEresistive exercise

resistive exercise by elastic band for 12 weeks

DEVICEaerobic exercise in form of treadmill walking

aerobic exercise in form of treadmill walking for 12 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Investigator, Outcomes Assessor)

Masking description

The allocation was concealed in sequentially numbered opaque envelopes by a blinded and an independent research assistant and selected 69 individuals randomly into the study.

Eligibility

Sex/Gender

FEMALE

Age

50 Years to 60 Years

Healthy volunteers

Inclusion criteria

* All women diagnosed as essential hypertension. * All women must be in their early postmenopausal period

Exclusion criteria

* Lesion to higher centers leading to hypertension (embolism) * any cardiovascular disease * premature menopause * surgical menopause * severe hypertension * diabetic * under treatment of hormonal therapy.

Design outcomes

Primary

Measure	Time frame	Description
Assessment of changes in the systolic blood pressure	12 weeks	using the mercury column sphygmomanometer

Secondary

Measure	Time frame	Description
Assessment of changes in the diastolic blood pressure	12 weeks	using the mercury column sphygmomanometer

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026